Fred Hutch researchers move closer to cracking the code on how genes and environmental factors influence colorectal cancer risk
March 17, 2015
| By Diane Mapes / Fred Hutch News Service
A new study by public health researchers at Fred Hutchinson Cancer Research Center has discovered that the benefits of using aspirin and NSAIDs like ibuprofen to cut colorectal cancer risk actually hinge on a person’s particular DNA.
Aspirin may cut pancreatic cancer risk, but should everyone take it?
June 27, 2014
| By Joely Johnson Mork
Aspirin may cut pancreatic cancer risk, according to a new study, but last month the FDA advised against healthy people taking it to prevent strokes and heart attacks due to potential side effects. Fred Hutch researchers help sort out the new findings.